PATHOGENIC KRAS MUTATIONS PROFILE IN PANCREATIC DUCTAL ADENOCARCINOMA

被引：0
|
作者：
Iacob, Razvan
Dima, Simona
Sorop, Andrei
Manea, Ioana
Ionescu, Victor S.
Spiridon, Andreea G.
Stoica, Bianca
Bunduc, Stefania
Chiosa, Andrei
Cazacu, Irina M.
Croitoru, Vlad M.
Chelaru, Raluca
Iacob, Speranta
Becheanu, Gabriel
Dumbrava, Mona
Herlea, Vlad
Croitoru, Adina E.
Csiki, Irma Eva
Ceafalan, Laura C.
Popescu, Irinel
Gheorghe, Cristian
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1254
引用
收藏
页码：S802 / S803
页数：2
相关论文
共 50 条
  • [1] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    [J]. PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [2] Allelic ratio of KRAS mutations in pancreatic ductal adenocarcinoma
    Lennerz, Jochen K.
    Stenzinger, Albrecht
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma
    Gomez-Tomas, Alvaro
    Pumarega, Jose
    Alguacil, Juan
    Amaral, Andre F. S.
    Malats, Nuria
    Pallares, Natalia
    Gasull, Magda
    Porta, Miquel
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2019, 60 (08) : 693 - 703
  • [4] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [5] Impact of KRAS mutations and co-mutations on clinical outcomes in Pancreatic Ductal Adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafti, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smalgo, Brandon
    Wolff, Robert
    Pant, Shubham
    Lee, Michael
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark
    Synder, Rebecca
    Katz, Matthew Harold
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [6] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafl, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smaglo, Brandon G.
    Wolff, Robert A.
    Pant, Shubham
    Lee, Michael S.
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark W.
    Snyder, Rebecca
    Katz, Matthew H. G.
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    [J]. NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [7] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Yousef, Abdelrahman
    Yousef, Mahmoud
    Chowdhury, Saikat
    Abdilleh, Kawther
    Knafl, Mark
    Edelkamp, Paul
    Alfaro-Munoz, Kristin
    Chacko, Ray
    Peterson, Jennifer
    Smaglo, Brandon
    Wolff, Robert
    Pant, Shubham
    Lee, Michael
    Willis, Jason
    Overman, Michael
    Doss, Sudheer
    Matrisian, Lynn
    Hurd, Mark
    Snyder, Rebecca
    Katz, Matthew
    Wang, Huamin
    Maitra, Anirban
    Shen, John Paul
    Zhao, Dan
    [J]. CANCER RESEARCH, 2024, 84 (02)
  • [8] Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
    Abdelrahman Yousef
    Mahmoud Yousef
    Saikat Chowdhury
    Kawther Abdilleh
    Mark Knafl
    Paul Edelkamp
    Kristin Alfaro-Munoz
    Ray Chacko
    Jennifer Peterson
    Brandon G. Smaglo
    Robert A. Wolff
    Shubham Pant
    Michael S. Lee
    Jason Willis
    Michael Overman
    Sudheer Doss
    Lynn Matrisian
    Mark W. Hurd
    Rebecca Snyder
    Matthew H. G. Katz
    Huamin Wang
    Anirban Maitra
    John Paul Shen
    Dan Zhao
    [J]. npj Precision Oncology, 8
  • [9] Pathogenic germline mutations prevalence in Saudi patients with pancreatic ductal adenocarcinoma
    Algarni, Mohammed Ahmed
    Alshammari, Kanan
    Al Olayan, Ashwaq
    Sabatin, Fouad
    Mabsout, Nadine
    Zaher, Horya
    Shehata, Husam
    Al Turki, Saeed
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [10] Diagnostic and Prognostic Value of Circulating KRAS Mutations in Resectable Pancreatic Ductal Adenocarcinoma
    Hipp, J.
    Hussung, S.
    Duyster, J.
    Fichtner-Feigl, S.
    Fritsch, R.
    Wittel, U. A.
    [J]. PANCREAS, 2018, 47 (10) : 1392 - 1392
12345